New York State Common Retirement Fund Vertex Pharmaceuticals Inc Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 359,479 shares of VRTX stock, worth $147 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
359,479
Previous 388,552
7.48%
Holding current value
$147 Million
Previous $182 Million
8.2%
% of portfolio
0.23%
Previous 0.24%
Shares
30 transactions
Others Institutions Holding VRTX
# of Institutions
1,724Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$10.9 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.45 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.7 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.82 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.67 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $105B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...